Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 142
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans
Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model
Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout
It’s Time to Push Back: Meta’s War on Psychedelic Voices
atai Life Sciences Secures Term Loan Facility for up to $175...
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million...
PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...
Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...
Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...
MindMed Strengthens Board with Appointment of Two New Independent Directors
Opinions | Hallucinations of Meaning: If you can lie, so can...
PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
Can Psilocybin Treat Obesity? New Evidence, Future Directions
1
...
141
142
143
...
291
Page 142 of 291